Evaluation of the Degradation Properties of Carbonate Substituted Hydroxyapatite-Poly(ε-caprolactone) Composites

Abstract:

The aim of this work is to produce and characterise carbonate substituted hydroxyapatite (CHA) reinforced polycaprolactone (PCL) nanocomposites with a controlled degradation rate in order to match the rate of bone in-growth. The ideal degradation time for this purpose is estimated to be around 5-6 months however, in vivo, PCL degrades over a period of 2 to 3 years. It has been reported that NaOH surface treatment can accelerate the degradation of PCL [1-3]. In order to further modify the degradation rate of PCL, the effects of the incorporation of different volume fractions of CHA in samples surface treated with NaOH was investigated. CHA was produced by wet chemical synthesis. Samples comprising 8, 19, 25 wt% uncalcined CHA-PCL composites were produced by twin screw extrusion which were then injection moulded into cylinders. In order to accelerate the degradation rate of PCL, it was surface treated with 5 M NaOH for 3 days prior to PBS studies. The degradation profile was examined by % weight loss and % water uptake measurements. NaOH treatment was observed to erode the polymer surface and the polymer-filler interface. On subsequently degrading the pre-treated samples in PBS, it was observed that with increasing fraction of CHA, the degradation rate in PBS of the sample increased. Up to 8 wt % CHA filler there appeared to be little change in the degradation properties of the NaOH treated samples with the onset occurring after 60 days. However there was a marked acceleration of degradation for samples containing 19 wt% when degradation appeared to occur immediately. In conclusion, the addition of CHA significantly affects the behaviour of PCL.

• Periodical: Key Engineering Materials (Volumes 493-494)
• Pages: 120-125
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.493-494.120
• Online since: October 2011
• Authors: Duygu Ege, Koonyang Lee, Alexandre Bismarck, Serena Best, Ruth Cameron
• Keywords: Carbonated Hydroxyapatite, Degradation Studies, NaOH Surface Treatment, Poly(ε-Caprolactone), Scanning Electron Microscope (SEM)

References

[1] Lam CXF, Savalani MM, Teoh SH, Hutmacher DW. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions. Biomedical Materials 2008; 3.

DOI: 10.1088/1748-6041/3/3/034108

[2] Kim HW. Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation. Journal of Biomedical Materials Research Part A 2007; 83A: 169.

DOI: 10.1002/jbm.a.31247

[3] Heo SJ, Kim SE, Wei J, Hyun YT, Yun HS, Kim DH, Shin JW. Fabrication and characterization of novel nano- and micro-HA/PCL composite scaffolds using a modified rapid prototyping process. Journal of Biomedical Materials Research Part A 2009; 89A: 108.

DOI: 10.1002/jbm.a.31726

[4] Porter A, Patel N, Brooks R, Best S, Rushton N, Bonfield W. Effect of carbonate substitution on the ultrastructural characteristics of hydroxyapatite implants. Journal of Materials Science-Materials in Medicine 2005; 16: 899.

DOI: 10.1007/s10856-005-4424-1

[5] Barralet J, Knowles JC, Best S, Bonfield W. Thermal decomposition of synthesised carbonate hydroxyapatite. Journal of Materials Science-Materials in Medicine 2002; 13: 529.

DOI: 10.1023/a:1015175108668

[6] Robinson JH, Best SM. Comparison of hydroxyapatite and AB-type carbonate-substituted hydroxyapatite suspensions for use in the reticulated foam method of scaffold production. Bioceramics 21 2009; 396-398: 649.

DOI: 10.4028/www.scientific.net/kem.396-398.649

[7] Robinson JH, Best SM, Ahmad Z, Edirisinghe MJ. The effect of reaction conditions on hydroxyapatite particle morphology and applications to the reticulated foam method of scaffold production. Bioceramics, Vol 20, Pts 1 and 2 2008; 361-363: 3.

[8] Barralet JE, Grover L, Gaunt T, Wright AJ, Gibson IR. Preparation of macroporous calcium phosphate cement tissue engineering scaffold. Biomaterials 2002; 23: 3063.

DOI: 10.1016/s0142-9612(01)00401-x

[9] Elzubair A, Elias CN, Suarez JCM, Lopes HP, Vieira MVB. The physical characterization of a thermoplastic polymer for endodontic obturation. Journal of Dentistry 2006; 34: 784.

DOI: 10.1016/j.jdent.2006.03.002

[10] Tiaw KS, Goh SW, Hong M, Wang Z, Lan B, Teoh SH. Laser surface modification of poly(epsilon-caprolactone) (PCL) membrane for tissue engineering applications. Biomaterials 2005; 26: 763.

DOI: 10.1016/j.biomaterials.2004.03.010

[11] Tsuji H, Suzuyoshi K, Tezuka Y, Ishida T. Environmental degradation of biodegradable polyesters: 3. Effects of alkali treatment on biodegradation of poly(epsilon-caprolactone) and poly (R)-3-hydroxybutyrate films in controlled soil. Journal of Polymers and the Environment 2003; 11: 57.

DOI: 10.1002/app.12781

[12] Tsuji H, Ishida T. Poly(L-lactide). X. Enhanced surface hydrophilicity and chain-scission mechanisms of poly(L-lactide) film in enzymatic, alkaline, and phosphate-buffered solutions. Journal of Applied Polymer Science 2003; 87: 1628.

DOI: 10.1002/app.11605

[13] Yeo A, Sju E, Rai B, Teoh SH. Customizing the Degradation and Load-Bearing Profile of 3D Polycaprolactone-Tricalcium Phosphate Scaffolds Under Enzymatic and Hydrolytic Conditions. Journal of Biomedical Materials Research Part B-Applied Biomaterials 2008; 87B: 562.

DOI: 10.1002/jbm.b.31145

[14] Yeo A, Wong WJ, Khoo HH, Teoh SH. Surface modification of PCL-TCP scaffolds improve interfacial mechanical interlock and enhance early bone formation: An in vitro and in vivo characterization. Journal of Biomedical Materials Research Part A 2010; 92A: 311.

DOI: 10.1002/jbm.a.32366

[15] Ang KC, Leong KF, Chua CK, Chandrasekaran M. Compressive properties and degradability of poly(epsilon-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradation. Journal of Biomedical Materials Research Part A 2007; 80A: 655.

DOI: 10.1002/jbm.a.30996

[16] Htay M. Water vapour transmission and degradation properties of biaxiallt stretched PCL films and cell-permeable membranes. Division of Bioengineering, vol. Master of Engineering, (2004).

[17] Rich J, Jaakkola T, Tirri T, Narhi T, Yli-Urpo A, Seppala J. In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)/bioactive glass composites. Biomaterials 2002; 23: 2143.

DOI: 10.1016/s0142-9612(01)00345-3

[18] Kikuchi M, Koyama Y, Yamada T, Imamura Y, Okada T, Shirahama N, Akita K, Takakuda K, Tanaka J. Development of guided bone regeneration membrane composed of beta-tricalcium phosphate and poly (L-lactide-co-glycolide-epsilon-caprolactone) composites. Biomaterials 2004; 25: 5979.

DOI: 10.1016/j.biomaterials.2004.02.001

[19] Gibson IR, Bonfield W. Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite. Journal of Biomedical Materials Research 2002; 59: 697.

DOI: 10.1002/jbm.10044